The Li-Fraumeni syndrome: An inherited susceptibility to cancer

Molecular Medicine Today

Volumn 3, Issue 9, 1997, Pages 390-395

  Evans, Susan C ^a   Lozano, Guillermina ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CANCER RISK; CARCINOGENESIS; FAMILIAL CANCER; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; REVIEW; TUMOR SUPPRESSOR GENE;

CELL CYCLE; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENES, DOMINANT; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; PEDIGREE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031414301     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01105-2     Document Type: Review

References (39)

1. Li, F.P. and Fraumeni, J.F., Jr (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann. Intern. Med. 71, 747-752
2. Li, F.P. and Fraumeni, J.F., Jr (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome, J. Natl. Cancer Inst. 43, 1365-1373
3. Li, F.P. et al. (1988) A cancer family syndrome in twenty-four kindreds, Cancer Res. 48, 5358-5362
4. Law, J.C., Strong, L.C., Chidambaram, A. and Ferrell, R.E. (1991) A germ line mutation in exon 5 of the p53 gene in an extended cancer family, Cancer Res. 51, 6385-6387
5. Kleihues, P. et al. (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families, Am. J. Pathol. 150, 1-13
6. Malkin, D. et al. (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms, Science 250, 1233-1238
7. Srivastava, S. et al. (1990) Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome, Nature 348, 747-749
8. Lustbader, E.D. et al. (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients, Am. J. Hum. Genet. 51, 344-356
9. Li, F.P. et al. (1992) Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals, J. Natl. Cancer Inst. 15, 1156-1160
10. Halevy, O., Michalovitz, D. and Oren, M. (1990) Different tumor-derived p53 mutants exhibit distinct biological activities, Science 250, 113-116
11. Maltzman, W. and Czyzyk, L. (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol. Cell. Biol. 4, 1689-1694
12. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V. and Kastan, M.D. (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation, Proc. Natl. Acad. Sci. U. S. A. 89, 7491-7495
13. Lu, X. and Lane, D.P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75, 765-778
14. Lin, D. et al. (1992) Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase, Proc. Natl. Acad. Sci. U. S. A. 89, 9210-9214
15. Martinez, J., Georgoff, I., Martinez, J. and Levine, A.J. (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein, Genes Dev. 5, 151-159
16. Yonish-Rouach, E. et al. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature 352, 345-347
17. Lane, D.P. (1992) p53, guardian of the genome, Nature 358, 15-16
18. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm, Genes Dev. 10, 1054-1072
19. El-Deiry, W.S. et al. (1993) WAF1, a potential mediator of p53 tumor suppression, Cell 75, 817-825
20. Harper, J.W. et al. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell 75, 805-816
21. Xiong, Y. et al. (1993) p21 is a universal inhibitor of cyclin kinases, Nature 366, 701-704
22. Kastan, M.B. et al. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell 71, 587-597
23. Momand, J. et al. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation, Cell 69, 1237-1245
24. Wu, X., Bayle, J.H., Olson, D. and Levine, A.J. (1992) The p53-mdm2 autoregulatory feedback loop, Genes Dev. 7, 1126-1132
25. Barak, Y., Juven, T., Haffner, R. and Oren, M. (1993) mdm2 expression is induced by wildtype p53 activity, EMBO J. 12, 461-468
26. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human box gene, Cell 80, 293-299
27. Fields, S. and Jang, S.K. (1990) Presence of a potent transcription activating sequence in the p53 protein, Science 249, 1046-1049
28. Raycroft, L., Wu, H. and Lozano, G. (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene, Science 249, 1049-1051
29. Wang, Y. et al. (1993) p53 domains: identification and characterization of two autonomous DNA-binding regions, Genes Dev. 7, 2575-2586
30. Bargonetti, J. et al. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein, Genes Dev. 7, 2565-2574
31. Pavletich, N.P., Chambers, K.A. and Pabo, C.O. (1993) The DNA-binding domain of p53 contains the four conserved regions at the major mutation hotspots, Genes Dev. 7, 2556-2564
32. Cho, Y., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science 265, 346-355
33. El-Diery, W.S. et al. (1992) Definition of a consensus binding site for p53, Nat. Genet. 1, 45-49
34. Funk, W.D. et al. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol. 12, 2866-2871
35. Jeffrey, P.D., Gorina, S. and Pavletich, N.P. (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms, Science 267, 1498-1502
36. Shaulsky, G. et al. (1991) Nuclear localization is essential for the activity of p53 protein, Oncogene 6, 2055-2065
37. Hollstein, M. et al. (1997) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation, Nucleic Acids Res. 24, 141-146
38. Birch, J.M. et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families, Cancer Res. 54, 1298-1304
39. Frebourg, T. et al. (1995) Germline p53 mutations in 15 families with Li-Fraumeni syndrome, Am. J. Hum. Genet. 56, 608-615